Science Explorer Back to mapMap
Discussion
Researcher · KU Leuven · Belgium

Jonas Demeulemeester

Jonas Demeulemeester publishes mostly in Molecular Biology, Cancer Research and Infectious Diseases, on topics such as Cancer Genomics and Diagnostics, HIV Research and Treatment and HIV/AIDS drug development and treatment.

ORCID 0000-0002-2660-2478 OpenAlex
World rank
#70,447
of 7,710,434 ranked researchers
Rank in Belgium
#392
of 67,186
Works
270
Citations
24k
Citations per work
87.2
h-index
56
i10-index 106Top 2.6% in Molecular Biology
Jonas Demeulemeester

What does Jonas Demeulemeester research?

Jonas Demeulemeester's work is mostly in Biochemistry, Genetics and Molecular Biology (53%), Medicine (12%), Immunology and Microbiology (8%).

Life Sciences: 166 works · 61.3% of their workBiochemistry, Genetics and Molecular Biology: 144 works · 53.3% of their workMolecular Biology: 83 works · 30.8% of their workCancer Research: 40 works · 14.9% of their workGenetics: 21 works · 7.6% of their workImmunology and Microbiology: 22 works · 8.0% of their workVirology: 22 works · 8.0% of their workEverything else: 71 works · 26.4% of their workHealth Sciences: 33 works · 12.3% of their workMedicine: 33 works · 12.3% of their workInfectious Diseases: 22 works · 8.0% of their workOncology: 12 works · 4.3% of their workTHEIR WORKJonasDemeulemeester270works
Life Sciences61%Health Sciences12%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology14453.3%
    2. Immunology and Microbiology228.0%
  2. Everything else7126.4%
    1. Medicine3312.3%
  1. 1Molecular Biology31% of their works
  2. 2Cancer Research15% of their works
  3. 3Infectious Diseases8% of their works
  4. 4Virology8% of their works
  5. 5Genetics8% of their works
  6. 6Oncology4% of their works

Research topics

Which keywords describe Jonas Demeulemeester's research?

The keywords of their largest research topics: Antiretroviral Therapy, Cancer Genomics, Mutational Signatures, AIDS, HIV, Drug Resistance, HIV Infection and m6A-seq.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Antiretroviral Therapy912 topics
  2. Cancer Genomics751 topic
  3. Mutational Signatures751 topic
  4. AIDS481 topic
  5. HIV481 topic
  6. Drug Resistance431 topic
  7. HIV Infection431 topic
  8. RNA methylation231 topic
  9. m6A-seq231 topic
  10. Alternative Splicing161 topic
  11. RNA-Binding Proteins161 topic
  12. Enzyme Regulation141 topic
  13. Microsatellite Instability141 topic
  14. Molecular Characterization141 topic
  15. Nucleotide Metabolism141 topic
  16. Single-Cell141 topic
  17. Transcriptomics141 topic

Where does Jonas Demeulemeester work?

Jonas Demeulemeester's main affiliation in the publication record is KU Leuven, Belgium.

How many publications and citations does Jonas Demeulemeester have?

OpenAlex counts 270 works and 23,542 citations for Jonas Demeulemeester, an h-index of 56, ranking #70,447 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jonas Demeulemeester. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.